EBR

RADIATION2 trials

Sponsors

Ontario Clinical Oncology Group (OCOG), Lipomedix Pharmaceuticals Inc.

Conditions

CancerMetastatic DiseaseNon-small Cell Lung CancerSolid Tumor

Phase 1

Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients

CompletedNCT03823989

Lipomedix Pharmaceuticals Inc.Cancer, Metastatic Disease, Solid Tumor

Start: 2019-01-03End: 2021-12-30Updated: 2022-01-06

Phase 3

A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy

CompletedNCT01351116

Ontario Clinical Oncology Group (OCOG)Non-small Cell Lung Cancer

Start: 2011-10-31End: 2017-01-31Updated: 2017-01-24